This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Korea Hydro Nuclear Power Co., Ltd.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Byulnim Hwang: Innovator in Cancer Research
Introduction
Byulnim Hwang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research, particularly in understanding the mechanisms of thymic lymphoma. His innovative work has led to the development of a method for detecting apoptosis regulatory genes, which has important implications for cancer diagnosis and treatment.
Latest Patents
Hwang holds a patent for an "Apoptosis regulatory gene detected in irradiated-thymic lymphoma cell and method for detecting same." This patent describes a method for detecting an apoptosis regulatory gene in low-dose-rate and low-level-irradiated thymic lymphoma cells of mice. The invention reveals the function of the apoptosis regulatory gene through irradiation and provides a gene profile that can assess the dose-response relationship for industrial and healthcare workers exposed to low-level radiation. The detected gene serves as an index for evaluating cancer progression and treatment efficacy in patients with thymic lymphoma. Additionally, the method is utilized to prepare a diagnostic composition and kit for thymic lymphoma.
Career Highlights
Byulnim Hwang is currently employed at Korea Hydro & Nuclear Power Company Ltd. His work at this institution has allowed him to focus on innovative research that bridges the gap between nuclear science and healthcare. Hwang's dedication to advancing cancer research has positioned him as a key figure in his field.
Collaborations
Hwang collaborates with notable colleagues, including Hee Sun Kim and Hoon Moo Choi. Their combined expertise enhances the research efforts and contributes to the development of effective diagnostic tools for cancer.
Conclusion
Byulnim Hwang's contributions to cancer research through his innovative patent demonstrate his commitment to improving healthcare outcomes. His work not only advances scientific understanding but also provides practical applications for diagnosing and treating thymic lymphoma.